MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejogrb.2011.02.005

Медицинская библиотека · European journal of obstetrics, gynecology, and reproductive biology · 2011

Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia.

Mandelbrot Laurent, Mazy Fabienne, Floch-Tudal Corinne, Meier Françoise, Azria Elie, Crenn-Hebert Catherine, Treluyer Jean Marc, Herinomenzanahary Evelyne, Ferreira Claudia, Peytavin Gilles

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVE

To study the impact on the neonate of maternal antiretroviral therapy with atazanavir (ATV).

STUDY

DESIGN

An observational study of 22 HIV-infected women receiving, for clinical indications, antiretroviral therapy with ATV 300 mg and ritonavir 100mg during pregnancy and their 23 HIV infants (including a twin pair).

RESULTS

Mothers had received ATV for a median duration of 19 months [range 3-49] by delivery. At delivery, plasma HIV-RNA was <40 copies/mL in all patients. Liver enzymes were normal in 19/22 patients, but one woman had grade 3-4 liver toxicity. Maternal serum bilirubin concentrations were above the upper limit of normal in most patients, with grade 3 toxicity in 5 patients. All but one woman had trough ATV concentrations during pregnancy above the minimum effective concentration. The median cord blood ATV concentration was 130 ng/mL [range<30-758]; the cord/maternal ratio was 21%. All neonates were born at term [median 38.2 weeks]. Three neonates had mildly elevated AST transaminase levels. Bilirubin concentrations at birth were significantly higher than maternal concentrations, with a median of 44 μm/L [range 24-129]; values on days 2-3 were 63 [8-212]. Five neonates had jaundice requiring phototherapy, without liver damage, and recovered without sequelae.

CONCLUSION

Neonates whose mothers were treated with ATV should be monitored for hyperbilirubinemia, which may be due to placental transfer of unconjugated bilirubin from the mother and/or a direct effect of transplacental ATV on bilirubin metabolism in the fetus.

Для цитирования: Mandelbrot Laurent, Mazy Fabienne, Floch-Tudal Corinne, Meier Françoise, Azria Elie, Crenn-Hebert Catherine, Treluyer Jean Marc, Herinomenzanahary Evelyne, Ferreira Claudia, Peytavin Gilles. Atazanavir in pregnancy: impact on neonatal hyperbilirubinemia.. European journal of obstetrics, gynecology, and reproductive biology. 2011. DOI: 10.1016/j.ejogrb.2011.02.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.